EWM
Essex Woodlands Management Portfolio holdings
AUM $279M
1-Year Return
29.39%
This Quarter Return
-34.68%
1 Year Return
+29.39%
3 Year Return
+195.65%
5 Year Return
+90.32%
10 Year Return
+273.6%
AUM
$251M
AUM Growth
-$230M
(-48%)
Cap. Flow
-$109M
Cap. Flow
% of AUM
-43.33%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
8
New
–
Increased
–
Reduced
1
Closed
1
Top Buys
No buys this quarter
Top Sells
| 1 |
CORI
Corium International, Inc.
CORI
|
+$89M |
| 2 |
Axogen
AXGN
|
+$19.8M |
Sector Composition
| 1 | Healthcare | 97.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RVNC
1
DELISTED
Revance Therapeutics, Inc.
RVNC
| $91.7M | 36.54% |
3,342,047
| – | – |
|
2
EyePoint Pharmaceuticals
EYPT
$924M
| $79.2M | 31.54% |
4,190,396
| – | – |
|
|
3
Axogen
AXGN
$753M
| $56M | 22.29% |
2,739,751
-971,360
| -26% | -$19.8M |
|
4
MediciNova
MNOV
$60.8M
| $14.6M | 5.82% |
1,170,370
| – | – |
|
|
ELGX
5
DELISTED
Endologix Inc
ELGX
| $5.36M | 2.13% |
125,747
| – | – |
|
|
CORI
6
DELISTED
Corium International, Inc.
CORI
| – | – |
-9,353,304
| Closed | -$89M |
|
7
Gyre Therapeutics
GYRE
$718M
| $625K | 0.25% |
10,483
| – | – |
|
|
ACUR
8
DELISTED
Acura Pharmaceuticals Inc
ACUR
| $215K | 0.09% |
1,956,397
| – | – |
|